Ensign Peak Advisors
SOPH icon

Ensign Peak Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Ensign Peak Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.71M Buy
681,812
+237,158
+53% +$1.71M 0.01% 538
2026
Q2 		$2.57M Sell
444,654
-300
-0.1% -$1.52K ﹤0.01% 689
2026
Q1 		$2.2M Buy
444,954
+262,540
+144% +$1.28M ﹤0.01% 694
2025
Q4 		$852K Sell
182,414
-12,768
-7% -$57.8K ﹤0.01% 848
2025
Q3 		$929K Sell
195,182
-54,762
-22% -$188K ﹤0.01% 1068
2025
Q2 		$775K Buy
+249,944
New +$745K ﹤0.01% 1391

Other funds holding SOPH

Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Alta Wealth Advisors
Alta Wealth Advisors Woburn, Massachusetts $380M AUM 32.41% 1-Year Est. Return
Next Century Growth Investors
Next Century Growth Investors Plymouth, Minnesota $1.57B AUM 96.5% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Hodges Capital Management
Hodges Capital Management Dallas, Texas $1.44B AUM 52.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Ensign Peak Advisors's SOPH Position: Q3 2026 in Review

Ensign Peak Advisors increased its SOPHiA GENETICS (SOPH) stake by 53% in Q3 2026, buying an estimated $1.71M and bringing the position to 681,812 shares worth $5.71M. The position accounts for 0.01% of the portfolio, ranked #538.

Ensign Peak Advisors first reported a position in SOPH in Q2 2025 and has held it in 6 quarters since. 56 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • Ensign Peak Advisors held 681,812 shares of SOPHiA GENETICS worth $5.71M as of Q3 2026.
  • Ensign Peak Advisors bought 237,158 SOPHiA GENETICS shares in Q3 2026, an estimated $1.71M.
  • SOPHiA GENETICS made up 0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #538 holding.
  • Ensign Peak Advisors first reported a position in SOPHiA GENETICS in Q2 2025 and has held it in 6 quarters since.
  • 56 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.